These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 21960174)

  • 21. Expression of extra domain A containing fibronectin in chronic cardiac allograft rejection.
    Franz M; Berndt A; Grün K; Richter P; Kosmehl H; Neri D; Gummert J; Figulla HR; Brehm BR; Renner A
    J Heart Lung Transplant; 2011 Jan; 30(1):86-94. PubMed ID: 20952210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy.
    Yang J; Popoola J; Khandwala S; Vadivel N; Vanguri V; Yuan X; Dada S; Guleria I; Tian C; Ansari MJ; Shin T; Yagita H; Azuma M; Sayegh MH; Chandraker A
    Circulation; 2008 Feb; 117(5):660-9. PubMed ID: 18212277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
    Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
    Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR; Chan SY; Goodman RE; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1996 Sep; 157(5):1951-7. PubMed ID: 8757314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reprogramming of vascular smooth muscle alpha-actin gene expression as an early indicator of dysfunctional remodeling following heart transplant.
    Subramanian SV; Kelm RJ; Polikandriotis JA; Orosz CG; Strauch AR
    Cardiovasc Res; 2002 Jun; 54(3):539-48. PubMed ID: 12031699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of recipient CCR5 promotes early and increased allospecific antibody responses to cardiac allografts.
    Amano H; Bickerstaff A; Orosz CG; Novick AC; Toma H; Fairchild RL
    J Immunol; 2005 May; 174(10):6499-508. PubMed ID: 15879153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prolonged murine cardiac allograft acceptance: characteristics of persistent active alloimmunity after treatment with gallium nitrate versus anti-CD4 monoclonal antibody.
    Orosz CG; Wakely E; Sedmak DD; Bergese SD; VanBuskirk AM
    Transplantation; 1997 Apr; 63(8):1109-17. PubMed ID: 9133472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting.
    Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R
    J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin α4β1 and TLR4 Cooperate to Induce Fibrotic Gene Expression in Response to Fibronectin's EDA Domain.
    Kelsh-Lasher RM; Ambesi A; Bertram C; McKeown-Longo PJ
    J Invest Dermatol; 2017 Dec; 137(12):2505-2512. PubMed ID: 28842322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular Fibronectin Containing Extra Domain A Causes Insulin Resistance via Toll-like Receptor 4.
    Rajak S; Hussain Y; Singh K; Tiwari S; Ahmad B; Bharti S; Prakash P
    Sci Rep; 2020 Jun; 10(1):9102. PubMed ID: 32499562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibronectin Containing Extra Domain A Induces Plaque Destabilization in the Innominate Artery of Aged Apolipoprotein E-Deficient Mice.
    Doddapattar P; Jain M; Dhanesha N; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):500-508. PubMed ID: 29326316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
    Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
    Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haptoglobin enhances cardiac transplant rejection.
    Shen H; Heuzey E; Mori DN; Wong CK; Colangelo CM; Chung LM; Bruce C; Slizovskiy IB; Booth CJ; Kreisel D; Goldstein DR
    Circ Res; 2015 May; 116(10):1670-9. PubMed ID: 25801896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extra domain A-containing fibronectin expression in Spin90-deficient fibroblasts mediates cancer-stroma interaction and promotes breast cancer progression.
    Kwon A; Chae IH; You E; Kim SH; Ahn SY; Lee OJ; Park ZY; Rhee S; Huh YH; Song WK
    J Cell Physiol; 2020 May; 235(5):4494-4507. PubMed ID: 31637720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cells in acute and chronic rejection of rat cardiac allografts--a major source of basic fibroblast growth factor.
    Koskinen PK; Kovanen PT; Lindstedt KA; Lemström KB
    Transplantation; 2001 Jun; 71(12):1741-7. PubMed ID: 11455252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. OX40 costimulation prevents allograft acceptance induced by CD40-CD40L blockade.
    Burrell BE; Lu G; Li XC; Bishop DK
    J Immunol; 2009 Jan; 182(1):379-90. PubMed ID: 19109169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
    Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
    Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A20 Attenuates the Fibrotic Response in the Trabecular Meshwork.
    Mzyk P; Zalog EG; McDowell CM
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo expression of fetal ED-A(+) fibronectin and B (+) tenascin-C splicing variants in human cardiac allografts: potential impact for targeted therapy of rejection.
    Franz M; Matusiak-Brückner M; Richter P; Grün K; Ziffels B; Neri D; Maschek H; Schulz U; Pfeil A; Jung C; Figulla HR; Gummert J; Berndt A; Renner A
    J Mol Histol; 2014 Oct; 45(5):519-32. PubMed ID: 24792713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.